These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 24080986)

  • 1. Serum analysis by 1H nuclear magnetic resonance spectroscopy: a new tool for distinguishing neuromyelitis optica from multiple sclerosis.
    Moussallieh FM; Elbayed K; Chanson JB; Rudolf G; Piotto M; De Seze J; Namer IJ
    Mult Scler; 2014 Apr; 20(5):558-65. PubMed ID: 24080986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica.
    Tortorella C; Ruggieri M; Di Monte E; Ceci E; Iaffaldano P; Direnzo V; Mastrapasqua M; Frigeri A; Amato MP; Hakiki B; Ghezzi A; Lugaresi A; De Luca G; Patti F; D'Amico E; Sola P; Simone AM; Svelto M; Livrea P; Trojano M
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1355-9. PubMed ID: 21622936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.
    Wang H; Wang K; Wang C; Zhong X; Qiu W; Hu X
    Mult Scler; 2013 Jun; 19(7):926-31. PubMed ID: 23012252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
    Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
    Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
    Gebregiworgis T; Nielsen HH; Massilamany C; Gangaplara A; Reddy J; Illes Z; Powers R
    J Proteome Res; 2016 Feb; 15(2):659-66. PubMed ID: 26759122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuromyelitis optica IgG and related clinical features of patients with neuromyelitis optica].
    You XF; Ye J; Li CJ; Liao ZY; Sun H
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2477-80. PubMed ID: 21092475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
    Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
    J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF; Parisi JE; Lennon VA; Benarroch EE; Lassmann H; Bruck W; Mandler RN; Weinshenker BG; Pittock SJ; Wingerchuk DM; Lucchinetti CF
    Brain; 2007 May; 130(Pt 5):1194-205. PubMed ID: 17282996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
    Kim W; Lee JE; Li XF; Kim SH; Han BG; Lee BI; Kim JK; Choi K; Kim HJ
    Mult Scler; 2012 May; 18(5):578-86. PubMed ID: 21965418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
    Wang KC; Lee CL; Chen SY; Chen JC; Yang CW; Chen SJ; Tsai CP
    J Interferon Cytokine Res; 2013 Feb; 33(2):58-64. PubMed ID: 23398365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
    Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
    PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic criteria in acute neuromyelitis].
    Panea C; Petrescu S; Monica P; Voinea L; Dascălu AM; Nicolae M; Ungureanu E; Panca A; Grădinaru S
    Oftalmologia; 2007; 51(4):116-20. PubMed ID: 18543687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
    Papais-Alvarenga RM; Vasconcelos CC; Alves-Leon SV; Batista E; Santos CM; Camargo SM; Godoy M; Lacativa MC; Lorenti M; Damasceno B; Damasceno A; Brum D; Barreira AA; Guimarães Rocha MS; Alvarenga H; Tilbery CP
    Mult Scler; 2014 Mar; 20(3):374-81. PubMed ID: 23970504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of diagnostic value for NMO-IgG in patients with neuromyelitis optica].
    Yang Y; Huang DH; Wu L; Wu WP
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):606-9. PubMed ID: 20450783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets.
    Ip PP; Chung CY; Chang CC; Lee YF; Wang HM; Lian IB; Fann CS; Yang CC; Liao F
    J Neuroimmunol; 2018 May; 318():45-52. PubMed ID: 29455925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis.
    Feng X; Reder NP; Yanamandala M; Hill A; Franek BS; Niewold TB; Reder AT; Javed A
    J Neurol Sci; 2012 Feb; 313(1-2):48-53. PubMed ID: 22036215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
    Karussis D
    J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.